Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01966471 |
|---|---|
| Brief Title: | A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer |
| First Submitted : | October 17, 2013 |
| First Submitted that Met QC Criteria : | October 17, 2013 |
| First Posted : | October 21, 2013 (Estimate) |
| Results First Submitted : | November 17, 2020 |
| Results First Submitted that Met QC Criteria : | December 18, 2020 |
| Results First Posted : | January 12, 2021 |
| Last Update Submitted that Met QC Criteria : | June 13, 2022 |
| Last Update Posted : | June 14, 2022 |